- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x ARG- ALA- GLY- PHE- VAL- ALA- ASN- PHE: 8-mer model peptide(Non-covalent)
- 1 x ZN: ZINC ION(Non-covalent)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 35 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 6 residues within 4Å:- Chain A: G.208, A.237, D.239, T.241, Q.243
- Chain B: R.13
Ligand excluded by PLIPEDO.5: 4 residues within 4Å:- Chain A: D.38
- Chain B: S.53, D.54, L.55
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: R.7, F.9, Y.28, D.30
- Chain B: Y.64
Ligand excluded by PLIPEDO.7: 3 residues within 4Å:- Chain A: G.238, G.240
- Ligands: EDO.23
Ligand excluded by PLIPEDO.8: 6 residues within 4Å:- Chain A: E.213, I.214, T.215, Q.263, H.264, E.265
Ligand excluded by PLIPEDO.9: 3 residues within 4Å:- Chain A: E.223, D.224
- Ligands: TRS.3
Ligand excluded by PLIPEDO.10: 2 residues within 4Å:- Chain A: Y.86, K.122
Ligand excluded by PLIPEDO.11: 3 residues within 4Å:- Chain A: R.45, M.46, W.61
Ligand excluded by PLIPEDO.12: 5 residues within 4Å:- Chain A: G.105, S.106, G.108, L.173, Q.181
Ligand excluded by PLIPEDO.13: 4 residues within 4Å:- Chain A: L.231, V.232, E.233, K.244
Ligand excluded by PLIPEDO.14: 2 residues within 4Å:- Chain A: P.16, G.17
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: R.146, K.147, A.150
- Ligands: EDO.22
Ligand excluded by PLIPEDO.16: 5 residues within 4Å:- Chain A: H.189, T.191, W.205, L.207
- Ligands: EDO.29
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain A: K.69, A.70, Q.73
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain A: S.3, H.4, R.7, D.103
Ligand excluded by PLIPEDO.19: 4 residues within 4Å:- Chain A: F.110, L.111, R.112, E.129
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain A: Y.85, M.139, A.140, I.143
Ligand excluded by PLIPEDO.21: 5 residues within 4Å:- Chain A: R.15, E.20, P.21, S.39, D.40
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain A: I.143, R.146
- Ligands: EDO.15
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: D.31, P.236, G.240, F.242
- Ligands: EDO.7
Ligand excluded by PLIPEDO.24: 4 residues within 4Å:- Chain A: A.159, Y.160, T.164
- Ligands: ARG-ALA-GLY-PHE-VAL-ALA-ASN-PHE.1
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain A: A.150, A.151, H.152
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain A: N.87, Q.88, S.89
Ligand excluded by PLIPEDO.27: 3 residues within 4Å:- Chain A: L.273, R.274, E.276
Ligand excluded by PLIPEDO.28: 2 residues within 4Å:- Chain A: P.51, E.54
Ligand excluded by PLIPEDO.29: 9 residues within 4Å:- Chain A: L.207, R.235, Q.243
- Chain B: Y.11, S.12, H.14, P.15, M.100
- Ligands: EDO.16
Ligand excluded by PLIPEDO.30: 7 residues within 4Å:- Chain B: Q.9, V.10, V.94, K.95, W.96, D.97, M.100
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain A: R.22, I.24
- Chain B: S.34, D.35
Ligand excluded by PLIPEDO.32: 7 residues within 4Å:- Chain A: F.9, M.99, Q.116
- Chain B: F.57, S.58, K.59, W.61
Ligand excluded by PLIPEDO.33: 3 residues within 4Å:- Chain B: R.13, F.23, Y.68
Ligand excluded by PLIPEDO.34: 4 residues within 4Å:- Chain A: E.233
- Chain B: S.58, K.59, D.60
Ligand excluded by PLIPEDO.35: 2 residues within 4Å:- Chain B: E.51, H.52
Ligand excluded by PLIPEDO.36: 7 residues within 4Å:- Chain B: L.41, N.43, G.44, E.78, Y.79, A.80, K.95
Ligand excluded by PLIPEDO.37: 5 residues within 4Å:- Chain A: H.71, T.74
- Ligands: ARG-ALA-GLY-PHE-VAL-ALA-ASN-PHE.1, ARG-ALA-GLY-PHE-VAL-ALA-ASN-PHE.1, EDO.38
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain A: Q.156
- Ligands: ARG-ALA-GLY-PHE-VAL-ALA-ASN-PHE.1, ARG-ALA-GLY-PHE-VAL-ALA-ASN-PHE.1, ARG-ALA-GLY-PHE-VAL-ALA-ASN-PHE.1, EDO.37
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Asa, M. et al., Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. J.Biol.Chem. (2022)
- Release Date
- 2022-06-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 1 x ARG- ALA- GLY- PHE- VAL- ALA- ASN- PHE: 8-mer model peptide(Non-covalent)
- 1 x ZN: ZINC ION(Non-covalent)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 35 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Asa, M. et al., Crystal structures of N-myristoylated lipopeptide-bound HLA class I complexes indicate reorganization of B-pocket architecture upon ligand binding. J.Biol.Chem. (2022)
- Release Date
- 2022-06-22
- Peptides
- MHC class I antigen: A
Beta-2-microglobulin: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B